From: Elevated pleural effusion IL-17 is a diagnostic marker and outcome predictor in lung cancer patients
Clinical variables | Patients ( n) | IL-17 (pg/ml) Mean ± SD | P-value |
---|---|---|---|
Age (years) | 0.343 | ||
≥60 | 38 | 27.08 ± 4.87 | |
<60 | 40 | 19.92 ± 5.28 | |
Gender | 0.259 | ||
Male | 36 | 21.23 ± 5.30 | |
Female | 42 | 19.87 ± 5.23 | |
Histologic type | 0.491 | ||
Adenocarcinoma | 67 | 20.33 ± 6.12 | |
Nonadenocarcinoma | 11 | 21.52 ± 5.05 | |
ECOG PS | 0.256 | ||
0 or 1 | 50 | 19.99 ± 5.37 | |
2 to 4 | 28 | 21.41 ± 5.21 | |
Cytologic examination | 0.912 | ||
Positive | 60 | 20.46 ± 5.18 | |
Negative | 18 | 20.62 ± 6.12 | |
Stage | 0.706 | ||
M1a | 54 | 20.34 ± 4.58 | |
M1b | 24 | 20.83 ± 6.01 | |
Location | 0.751 | ||
Right | 50 | 20.34 ± 5.36 | |
Left | 28 | 20.15 ± 4.97 |